Fig 2.

Combination treatment with 5-Fu and CP-25 inhibited tumorigenicity in vivo. a: Representative images of the liver tumors in the different groups. b, c: The final tumor weight and volume in each group after treatment. d, e: Representative images of hematoxylin and eosin (H&E) and tunel staining in each group (original magnification×200). f-h: The levels of ALT, AST, ALP, AFP in each group. All data are expressed as means ± standard deviation. ^#P< 0.05,^##P< 0.01, versus normal group; ^*P< 0.05, ^**P< 0.01, versus DEN-treated group, ^sP< 0.05, ^ssP< 0.01, versus CP-25 alone group; ^&P< 0.05, ^&&P< 0.01, versus normal group versus 5-Fu alone group.